Vpr is preferentially targeted by CTL during HIV-1 infection

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2743-2752

  Altfeld, M ^a   Addo, M M ^a   Eldridge, R L ^a   Yu, X G ^a   Thomas, S ^a   Khatri, A ^a   Strick, D ^a   Phillips, M N ^a   Cohen, G B ^a   Islam, S A ^a   Kalams, S A ^a   Brander, C ^a   Goulder, P J R ^a   Rosenberg, E S ^a   Walker, B D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; VIF PROTEIN; VIRUS PROTEIN; VPR PROTEIN; VPU PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; PROTEIN TARGETING; VIRUS REPLICATION;

EID: 0035451404     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2743     Document Type: Article

References (65)

1. T lymphocyte responses in HIV-1 infection: Implications for vaccine development
2. + T helper cells in the cytotoxic T lymphocyte response to HIV-1
3. Anti-HIV cellular immunity: Recent advances towards vaccine design
4. AIDS: Escape from the immune system
5. Cellular immune responses to HIV
6. The evolving field of HIV CRL epitope mapping: New approaches for the identification of novel epitopes
7. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
8. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T-lymphocytes (CTL) derived from HIV-1-infected individuals
9. HIV accessory proteins: Leading roles for the supporting cast
10. When accessories turn out to be essential
11. HIV-1: Fifteen proteins and an RNA
12. HIV-1 auxiliary proteins: Making connections in a dying cell
13. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology
14. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP)
15. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
16. HIV-specific cytotoxic T lymphocytes in seropositive individuals
17. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix
18. Analysis and sorting of T cells according to cytokine expression
19. + T cells based on cytokine secretion
20. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1
21. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells
22. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: Rapid characterization of CTL responses by enzyme-linked immunospot assay
23. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and Caucasoid adults and children
24. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
25. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children
26. Rapid definition of five novel HLA-A*3002-restricted human immunode-ficiency virus-specific cytotoxic T-lymphocyte epitopes by ELISPOT and intra-cellular cytokine staining assays
27. Immune control of HIV-1 after early treatment of acute infection
28. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides
29. MHC ligands and peptide motifs: First listing
30. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif
31. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection
32. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)- identical siblings with HLA-A-*0201 are influenced by epitope mutation
33. Recent advances in HIV-1 CTL epitope characterization
34. AIDS virus-specific cytotoxic T lymphocytes in lung disorders
35. Rapid characterization of HIV clade C-specific cytotoxic T lymphocyte responses in infected African children and adults
36. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells
37. Extent of incorporation of HIV-1 Vpr into the virus particles is flexible and can be modulated by expression level in cells
38. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
39. The putative α helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells
40. Nuclear import of human immunodeficiency virus type-1 preintegration complexes
41. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex
42. The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection
43. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents
44. Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
45. + T lymphocytes
46. Essential role of Vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages
47. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
48. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process
49. Two putative α-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms
50. 2 arrest, nuclear localization, and cell death in fission yeast
51. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr
52. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr
53. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation
54. The multimerization of human immunodeficiency virus type-I (HIV-1) Vif protein: A requirement for Vif function in the viral life-cycle
55. Mutational analysis of the human immunodeficiency virus type 1 Vif protein
56. Characterization of human immunodeficiency virus type 1 Vif particle incorporation
57. Identification of a functionally important amino acid residue near to the amino-terminus of the human immunodeficiency virus type 1 Vif protein
58. Mutational analysis of human immunodeficiency virus type 1 Vif gene
59. 2 arrest of the cell cycle
60. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope
61. Identification of highly attenuated mutants of simian immunodeficiency virus
62. Progression to AIDS in the absence of a gene for Vpr or vpx
63. Importance of Vpr for infection of rhesus monkeys with simian immunodeficiency virus